WP_BLADDER_CANCER | Return to index | ||||||||
Order | Gene | Description | ref_hepatocyte | HepG2 | HepG2.C3A | HuH.7 | SNU475 | THLE | liver |
1 | TYMP | Thymidine phosphorylase | [1] | -5.54[2] | -4.65[3] | -7.62[4] | -9.29[5] | -6.94[6] | -2.39[7] |
2 | CDKN1A | Cyclin-dependent kinase inhibitor 1 | [8] | -0.10[9] | -1.20[10] | -3.90[11] | -2.33[12] | 0.08[13] | -2.05[14] |
3 | MYC | Myc proto-oncogene protein | [15] | -0.50[16] | -0.56[17] | -2.60[18] | -3.14[19] | -0.90[20] | -2.21[21] |
4 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | [22] | -1.86[23] | -1.91[24] | -1.34[25] | -0.89[26] | -0.52[27] | -1.40[28] |
5 | MAP2K2 | Dual specificity mitogen-activated protein kinase kinase 2 | [29] | -0.88[30] | -0.92[31] | -0.06[32] | -1.19[33] | -0.84[34] | -1.91[35] |
6 | CCND1 | G1/S-specific cyclin-D1 | [36] | 2.12[37] | -0.10[38] | 0.72[39] | 1.53[40] | -0.08[41] | 0.84[42] |
7 | CDK4 | Cyclin-dependent kinase 4 | [43] | 0.40[44] | 1.26[45] | 0.88[46] | -0.17[47] | 0.35[48] | -1.05[49] |
8 | DAPK3 | Death-associated protein kinase 3 | [50] | -1.55[51] | -1.47[52] | -1.66[53] | -1.11[54] | -0.98[55] | -2.77[56] |
9 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | [57] | -1.00[58] | -0.31[59] | 0.95[60] | -0.53[61] | 0.19[62] | 0.88[63] |
10 | VEGFA | Vascular endothelial growth factor A | [64] | 0.28[65] | 1.91[66] | 0.49[67] | 0.09[68] | 0.66[69] | 0.57[70] |
11 | NRAS | GTPase NRas | [71] | -0.30[72] | 0.41[73] | 0.81[74] | 0.65[75] | 0.08[76] | -0.46[77] |
12 | ARAF | Serine/threonine-protein kinase A-Raf | [78] | -1.39[79] | -1.41[80] | -1.15[81] | -0.44[82] | -0.55[83] | 0.66[84] |
13 | CDH1 | Cadherin-1 | [85] | 0.18[86] | 0.95[87] | 1.47[88] | -3.52[89] | -7.91[90] | 1.35[91] |
14 | HRAS | GTPase HRas | [92] | -1.94[93] | -2.36[94] | -3.17[95] | -1.29[96] | -1.65[97] | -2.87[98] |
15 | RASSF1 | Ras association domain-containing protein 1 | [99] | -1.99[100] | -1.56[101] | -1.95[102] | -1.84[103] | -0.56[104] | -2.12[105] |
16 | MAPK1 | Mitogen-activated protein kinase 1 | [106] | 0.77[107] | 1.20[108] | 1.01[109] | 1.50[110] | 1.01[111] | 1.56[112] |
17 | MMP1 | Interstitial collagenase | [113] | -6.10[114] | -9.59[115] | [116] | -2.10[117] | -2.69[118] | -12.34[119] |
18 | THBS1 | Thrombospondin-1 | [120] | 1.57[121] | -2.98[122] | -2.99[123] | 2.49[124] | 2.05[125] | 0.90[126] |
19 | KRAS | GTPase KRas | [127] | -1.45[128] | -1.18[129] | 0.40[130] | 0.46[131] | -0.03[132] | 0.46[133] |
20 | FGFR3 | Fibroblast growth factor receptor 3 | [134] | 1.79[135] | 1.99[136] | 2.31[137] | -3.64[138] | -2.43[139] | 0.24[140] |
21 | PIK3R1 | Phosphatidylinositol 3-kinase regulatory subunit alpha | [141] | -1.41[142] | -1.00[143] | 0.07[144] | 1.72[145] | 1.08[146] | 2.79[147] |
22 | ERBB2 | Receptor tyrosine-protein kinase erbB-2 | [148] | 1.44[149] | 0.54[150] | 1.70[151] | 0.91[152] | 0.38[153] | -0.06[154] |
23 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | [155] | 1.17[156] | 2.88[157] | 0.10[158] | 0.16[159] | 0.90[160] | 1.95[161] |
24 | EGFR | Epidermal growth factor receptor | [162] | -1.63[163] | -1.72[164] | 1.15[165] | 0.09[166] | 0.57[167] | 2.44[168] |
25 | TP53 | Cellular tumor antigen p53 | [169] | 0.70[170] | 0.55[171] | 1.30[172] | 0.95[173] | 0.47[174] | -0.25[175] |
26 | PIK3R2 | Phosphatidylinositol 3-kinase regulatory subunit beta | [176] | 0.94[177] | 1.45[178] | 2.04[179] | 0.36[180] | 0.78[181] | -0.50[182] |
27 | SRC | Proto-oncogene tyrosine-protein kinase Src | [183] | 2.09[184] | 2.36[185] | 1.35[186] | 2.05[187] | 1.09[188] | -1.06[189] |
28 | DAPK1 | Death-associated protein kinase 1 | [190] | 0.14[191] | 0.41[192] | 1.37[193] | 0.36[194] | 0.37[195] | 2.49[196] |
29 | RB1 | Retinoblastoma-associated protein | [197] | 0.28[198] | 1.07[199] | 1.62[200] | 1.93[201] | 2.12[202] | 1.26[203] |
30 | E2F1 | Transcription factor E2F1 | [204] | 1.01[205] | 1.15[206] | 1.27[207] | 1.52[208] | 1.82[209] | -3.83[210] |
31 | HBEGF | Proheparin-binding EGF-like growth factor | [211] | -1.92[212] | -2.45[213] | -3.53[214] | -0.04[215] | -0.49[216] | -2.64[217] |
32 | BRAF | Serine/threonine-protein kinase B-raf | [218] | -0.69[219] | -0.67[220] | 1.35[221] | 0.39[222] | -0.05[223] | 1.64[224] |
33 | MMP9 | Matrix metalloproteinase-9 | [225] | -3.65[226] | -4.42[227] | -6.83[228] | -1.78[229] | -4.48[230] | -0.35[231] |
34 | UPK3A | Uroplakin-3a | [232] | 0.59[233] | 2.91[234] | -6.12[235] | [236] | [237] | [238] |
35 | RPS6KA5 | Ribosomal protein S6 kinase alpha-5 | [239] | [240] | [241] | [242] | [243] | [244] | [245] |
36 | CDKN2A | Cyclin-dependent kinase inhibitor 2A | [246] | 3.15[247] | 1.20[248] | 4.59[249] | 4.86[250] | 6.51[251] | -2.37[252] |
37 | DAPK2 | Death-associated protein kinase 2 | [253] | -1.83[254] | -2.89[255] | 1.77[256] | 0.92[257] | -0.53[258] | 0.82[259] |
38 | MMP2 | 72 kDa type IV collagenase | [260] | 2.50[261] | -4.20[262] | -2.94[263] | 7.09[264] | 6.50[265] | 3.72[266] |
39 | EGF | Pro-epidermal growth factor | [267] | 1.03[268] | 3.11[269] | 6.71[270] | 8.68[271] | 5.96[272] | 1.37[273] |
40 | CXCL8 | Interleukin-8 | [274] | [275] | [276] | [277] | [278] | [279] | [280] |
41 | MIR637 | [281] | [282] | [283] | [284] | [285] | [286] | [287] |